Stephen M. Dunn
Amministratore Delegato presso Nextwave Research, Inc.
Provenienza dei contatti di primo grado di Stephen M. Dunn
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
TAXIS Pharmaceuticals, Inc.
TAXIS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology TAXIS Pharmaceuticals, Inc develops antibiotics for the treatment of multidrug-resistant bacteria. The company was founded by Edmond J. LaVoie, Gregory G. Mario and Daniel S. Pilch in 2009 and is headquartered in Monmouth Junction, NJ.
5
| Holding Company | Pharmaceuticals: Major | 5 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Stephen M. Dunn tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
ALZA CORPORATION | Pharmaceuticals: Major | Chief Executive Officer | |
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
CELGENE | Biotechnology | Director/Board Member | |
BOSTON SCIENTIFIC CORPORATION | Medical Specialties | Director/Board Member | |
Pharmaceutical Product Development LLC
Pharmaceutical Product Development LLC Miscellaneous Commercial ServicesCommercial Services Pharmaceutical Product Development LLC engages in the operation of a global contract research organization, which provides drug development, laboratory and lifecycle management services. It offers adaptive trial design, bio analytical lab, bio similar development, biostatistics, GMP lab, clinical supplies, trial monitoring, CMC regulatory, data management, dental pain clinic, real-world outcomes, site intelligence and activation, central lab, global regulatory affairs, IRT systems, late stage research, medical communications, device and diagnostics, medical writing, nonclinical development and regulatory consulting and intelligence, regulatory development, innovation and vaccine sciences. The company was founded by Fredric N. Eshelman in 1985 and is headquartered in Wilmington, NC. | Miscellaneous Commercial Services | Chairman | |
Maxygen, Inc.
Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Maxygen, Inc. is a biotechnology company. It is focused on the potential further development of its MAXY-G34 product, a next-generation pegylated, granulocyte colony stimulating factor, G-CSF, for the treatment of chemotherapy induced neutropenia and acute radiation syndrome. G-CSF is a natural protein that functions by stimulating the body's bone marrow to produce more white blood cells. The company was founded on May 7, 1996 and is headquartered in San Mateo, CA. | Miscellaneous Commercial Services | Director/Board Member | |
LEXICON PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Reliant Pharmaceuticals LLC
Reliant Pharmaceuticals LLC Miscellaneous Commercial ServicesCommercial Services Reliant Pharmaceuticals, Inc. sells, markets and develops cardiovascular pharmaceutical products. The company focuses on marketing promotionally sensitive pharmaceutical products to the primary care, cardiovascular and specialist physician markets in the United States. The company is headquartered in Liberty Corner, NJ | Miscellaneous Commercial Services | Chief Executive Officer | |
Pharmacopeia LLC
Pharmacopeia LLC Pharmaceuticals: MajorHealth Technology Pharmacopeia LLC develops small molecule therapeutics to address significant medical needs. The firm operates as clinical development stage Biopharmaceutical Company which focuses on discovering and developing novel small molecule therapeutics to address medical needs. The company was founded by John J. Baldwin in February 2002 and is headquartered in Cranbury, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Metalmark Capital LLC
Metalmark Capital LLC Investment ManagersFinance Metalmark Capital LLC (Metalmark Capital) is a private equity firm founded by John J. Moon in 1986. The firm is headquartered in New York. | Investment Managers | Consultant / Advisor | |
ALEXZA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Prestwick Pharmaceuticals, Inc.
Prestwick Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Prestwick Pharmaceuticals, Inc. develops drugs for diseases related to the central nervous system. Its drugs are used in curing diseases such as Huntington's, Parkinson's, restless legs syndrome, schizophrenia, autism, Alzheimer's, and sleep apnea diseases. The company was founded in 2002 and is headquartered in Washington DC. | Pharmaceuticals: Major | Director/Board Member | |
Avid Radiopharmaceuticals, Inc.
Avid Radiopharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Avid Radiopharmaceuticals, Inc. provides molecular imaging services. It develops new molecular imaging agents capable of changing the medical management of significant, chronic human diseases by identifying the first stages of pathological change, potentially assisting in earlier diagnosis, and better management and development of new therapies. The company was founded by Daniel M. Skovronsky in 2004 and is headquartered in Philadelphia, PA. | Medical/Nursing Services | Director/Board Member | |
SOLENO THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman | |
TARIS BioMedical LLC
TARIS BioMedical LLC Pharmaceuticals: MajorHealth Technology TARIS BioMedical LLC operates as a clinical-stage pharmaceutical company. It specializes in urology, continuous local dosing, bladder diseases, oncology, voiding dysfunction. The company was founded by Robert S. Langer Jr., Christine Bunt, and Michael J. Cima in 2008 and is headquartered in Lexington, MA. | Pharmaceuticals: Major | Director/Board Member | |
Delpor, Inc.
Delpor, Inc. Pharmaceuticals: MajorHealth Technology Delpor, Inc. develops therapeutic products. Its products include DLP-114, DLP-119, DLP-202 and DLP-414. The company was founded by Tassos Nicolaou and Frank Martin in 2009 and is headquartered in San Francisco, CA. | Pharmaceuticals: Major | Director/Board Member | |
The Trustees of Columbia University in The City of New York | College/University | Doctorate Degree | |
Duke University
Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Director/Board Member | |
Duke University Health System, Inc.
Duke University Health System, Inc. Medical/Nursing ServicesHealth Services Duke University Health System, Inc. engages in the provision of health care services. It offers cancer treatment, primary care, orthopedics, aesthetics, and fertility services. The company was founded in 1998 and is headquartered in Durham, NC. | Medical/Nursing Services | Chairman | |
Apothogen, Inc.
Apothogen, Inc. Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, Apothogen, Inc. is a company that develops and markets pharmaceuticals. The company is based in Raleigh, NC. Apothogen was acquired by IntraBiotics Pharmaceuticals, Inc. on April 24, 2002 for $1.81 million. | Pharmaceuticals: Major | Chairman | |
BMS, Inc.
BMS, Inc. Advertising/Marketing ServicesCommercial Services Part of Interspot, Inc., BMS, Inc. provides multimedia marketing services. The company is based in Portland, ME. BMS was acquired by Interspot, Inc. on February 25, 2000 for $1 million. | Advertising/Marketing Services | Corporate Officer/Principal | |
Pappas Capital LLC
Pappas Capital LLC Investment ManagersFinance Pappas Capital LLC (Pappas Ventures) is a venture capital firm founded in 1994 by Art M. Pappas. The firm is headquartered in Durham, North Carolina. | Investment Managers | Private Equity Investor | |
University of Rhode Island | College/University | Doctorate Degree | |
NEULAND LABORATORIES LIMITED | Pharmaceuticals: Major | Director/Board Member | |
Rutgers State University of New Jersey | College/University | Undergraduate Degree | |
Purdue University | College/University | Doctorate Degree | |
Hydra Biosciences, Inc.
Hydra Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Hydra Biosciences, Inc. develops pharmaceutical products. It is focused in major therapeutic areas, which include pain, inflammation, renal, anxiety, and pulmonary diseases. The company was founded by Laurie Bartlett Keating, Dean Y. Li, David E. Clapham, and Mark T. Keating in 2001 and is headquartered in Belmont, MA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Linden Manager LLC
Linden Manager LLC Investment ManagersFinance Linden Manager LLC (Linden Capital Partners) is a private equity firm founded in 2004 by Anthony B Davis and Brain C Miller. The firm is headquartered in Chicago, Illinois. | Investment Managers | Private Equity Investor | |
The State University of New York | College/University | Doctorate Degree | |
The North Carolina Biotechnology Center
The North Carolina Biotechnology Center Internet Software/ServicesTechnology Services The North Carolina Biotechnology Center provides research and education grants. Its services include financing, technology assessment, business planning, and marketing strategies implementation. The company was founded in 1984 and is headquartered in Research Triangle Park, NC. | Internet Software/Services | Director/Board Member | |
American Foundation for Pharmaceutical Education | Investment Trusts/Mutual Funds | Chairman | |
ALZA Pharmaceuticals | Chief Executive Officer | ||
Mario Family Partners
Mario Family Partners Investment ManagersFinance Mario Family Partners (Mario Family) is a venture capital firm founded in 2001 by Gregory Mario. The firm is headquartered in North Carolina. | Investment Managers | Founder | |
GlaxoSmithKline Services Unlimited
GlaxoSmithKline Services Unlimited Pharmaceuticals: MajorHealth Technology Glaxosmithkline Services Unlimited Ltd. develops, manufactures and markets pharmaceutical products. The company was incorporated on March 23, 1972 and is headquartered in Brentford, the United Kingdom. | Pharmaceuticals: Major | Chief Executive Officer | |
Celgene, Inc.
Celgene, Inc. Pharmaceuticals: MajorHealth Technology Part of Bristol Myers Squibb Co., Celgene, Inc. is a biopharmaceutical company that focuses on the discovery, development, and commercialization of therapies for the treatment of cancer and inflammatory diseases. The Canadian company's portfolio includes several approved products, such as REVLIMID, POMALYST, and OTEZLA, as well as a pipeline of investigational drugs. Celgene is committed to advancing the science of medicine and improving the lives of patients worldwide. | Pharmaceuticals: Major | Director/Board Member | |
Gladstone Foundation (CA) | Director/Board Member | ||
Balance Therapeutics, Inc.
Balance Therapeutics, Inc. BiotechnologyHealth Technology Balance Therapeutics, Inc. develops therapeutics to address conditions of intellectual disability. Its pharmacological approach, based on technology licensed from Stanford University, hypothesizes that restoring the proper balance between inhibition and excitation at the neuronal synapse by antagonizing excessive inhibitory circuits could result in the appropriate plasticity for memory and learning to occur in many conditions of intellectual disability. The company was founded by Lyndon Lien, Craig Garner and Daniel Wetmore in 2009 and is headquartered in San Bruno, CA. | Biotechnology | Director/Board Member | |
Neuland Laboratories, Inc.
Neuland Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Part of Neuland Laboratories Ltd., Neuland Laboratories, Inc. is a company that manufactures and exports pharmaceutical ingredients. The company is based in San Clemente, CA. | Pharmaceuticals: Major | Director/Board Member | |
EYENOVIA, INC. | Pharmaceuticals: Major | Director/Board Member | |
Orbus Therapeutics, Inc.
Orbus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Orbus Therapeutics, Inc. operates as a biopharmaceutical company focused on the development and commercialization of therapies that treat rare diseases. Its product eflornithine is a novel cytostatic agent, which the firm is developing to treat patients with recurrent anaplastic astrocytoma, a rare form of central nervous system cancer. The company was founded by Robert M. Myers and Jason D. Levin in 1998 and is headquartered in Palo Alto, CA. | Pharmaceuticals: Major | Chairman | |
Z53 Therapeutics LLC
Z53 Therapeutics LLC Pharmaceuticals: MajorHealth Technology Z53 Therapeutics LLC designs therapeutics to target tumors with p53 protein mutations. It develops zinc metallochaperones as drugs to reactivate the function of mutant p53 protein in cancer cells through restoration of p53 zinc binding and folding. The company was founded by Darren Carpizo and S. David Kimball and is headquartered in Cleveland, OH. | Pharmaceuticals: Major | Founder | |
Capnia, Inc.
Capnia, Inc. Medical SpecialtiesHealth Technology Capnia, Inc. develops diagnostics and devices to address unmet medical needs. Its CoSense® End-Tidal Carbon Monoxide Monitor product measures end-tidal carbon monoxide (ETCO) for the detection of dangerous hemolysis rates. The company is headquartered in Foster City, CA. | Medical Specialties | Chairman | |
Silver Bullet Therapeutics, Inc. | Director/Board Member |
Statistiche
Distribuzione geografica
Stati Uniti | 45 |
Regno Unito | 4 |
India | 2 |
Francia | 2 |
Canada | 2 |
Settori
Health Technology | 27 |
Finance | 7 |
Consumer Services | 7 |
Commercial Services | 5 |
Health Services | 3 |
Posizioni
Director/Board Member | 34 |
Independent Dir/Board Member | 12 |
Chairman | 11 |
Chief Executive Officer | 9 |
Corporate Officer/Principal | 6 |
Contatti più connessi
Insiders | |
---|---|
Ernest Mario | 44 |
S. David Kimball | 8 |
Cristopher Cimarusti | 6 |
Gregory G. Mario | 3 |
Ajit Parhi | 1 |
- Borsa valori
- Insiders
- Stephen M. Dunn
- Connessioni Società